Scimago Lab
powered by Scopus
call: +1.631.4701.9640
Mon-Fri 10 am - 2 pm EST


eISSN: 1643-3750

Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway

Pei Zhang, Hengliang Zhang, Yan Wang, Pan Zhang, Yan Qi

The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan, China (mainland)

Med Sci Monit 2019; 25:3366-3373

DOI: 10.12659/MSM.916299

Available online:

Published: 2019-05-07

BACKGROUND: The tripartite motif-containing protein 59 (TRIM59) is an important member of the TRIM family, which regulates biological processes. However, the relationship between TRIM59 and epithelial ovarian cancer (EOC) is not clear.
MATERIAL AND METHODS: The TRIM59 expression level was detected in EOC tissues and cell lines. CCK-8 assay, Transwell assay, and wound healing assay were performed to determine the effects of TRIM59 on EOC cell proliferation, invasion, and migration. Silencing of the expression of TRIM59 in EOC cells and expression of FAK/AKT/MMP pathway-related protein were detected by Western blot analysis.
RESULTS: Through bioinformatics analysis, TRIM59 was found to be highly expressed in EOC and was correlated with prognosis of patients. TRIM59 was upregulated in EOC tissues and cells. Silencing TRIM59 significantly suppressed EOC cell proliferation, migration, and invasion. In terms of molecular mechanism, silencing TRIM59 inhibited the FAK/AKT/MMP pathway.
CONCLUSIONS: TRIM59 is a biomarker for the prognosis of EOC. It is also oncogenic and a potential target for EOC therapy.

Keywords: Carcinoma, Ovarian Neoplasms, Prognosis